American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 27, Issue 1 , Pages 9-12 , January 2006

The potential impact of palivizumab on pediatric airway reconstruction

Presented at the Annual Meeting of The Society for Ear, Nose, and Throat Advances in Children, October 31, 2003 in New Orleans, LA.

  • Kevin Emerick, MD

      Affiliations

    • Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA
    • Department of Otology and Laryngology, Harvard Medical School, Boston, MA, USA
    • ,
  • Michael Cunningham, MD

      Affiliations

    • Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA
    • Department of Otology and Laryngology, Harvard Medical School, Boston, MA, USA
    • ,
  • Christopher Hartnick, MD

      Affiliations

    • Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA
    • Department of Otology and Laryngology, Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationCorresponding author. Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, 243 Charles St., Boston, MA 02114, USA. Tel.: +1 617 573 4206; fax: +1 617 573 6845.

References 

  1. Gustafson LM, Hartley BE, Liu JH, et al. Single-stage laryngotracheal reconstruction in children: a review of 200 cases. Otolaryngol Head Neck Surg. 2000;123:430–434
  2. Seid AB, Pransky SM, Kearns DB. One-stage laryngotracheoplasty. Arch Otolaryngol Head Neck Surg. 1991;117:408–410
  3. Monnier P, Lang F, Savary M. Cricotracheal resection for pediatric subglottic stenosis. Int J Pediatr Otorhinolaryngol. 1999;49(Suppl 1):S283–S286
  4. Monnier P, Savary M, Chapuis G. Cricotracheal resection for pediatric subglottic stenosis: update of the Lausanne experience. Acta Otorhinolaryngol Belg. 1995;49:373–382
  5. Lusk RP, Gray S, Muntz HR. Single-stage laryngotracheal reconstruction. Arch Otolaryngol Head Neck Surg. 1991;117:171–173
  6. Cotton RT, Gray SD, Miller RP. Update of the Cincinnati experience in pediatric laryngotracheal reconstruction. Laryngoscope. 1989;99:1111–1116
  7. Hartnick CJ, Hartley BE, Lacy PD, et al. Surgery for pediatric subglottic stenosis: disease-specific outcomes. Ann Otol Rhinol Laryngol. 2001;110:1109–1113
  8. Ludemann JP, Hughes CA, Noah Z, et al. Complications of pediatric laryngotracheal reconstruction: prevention strategies. Ann Otol Rhinol Laryngol. 1999;108:1019–1026
  9. Rothschild MA, Cotcamp D, Cotton RT. Postoperative medical management in single-stage laryngotracheoplasty. Arch Otolaryngol Head Neck Surg. 1995;121:1175–1179
  10. Kamal-Bahl S, Doshi J, Campbell J. Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review. Arch Pediatr Adolesc Med. 2002;156:1034–1041
  11. Simoes EAF. Respiratory syncytial virus infection. Lancet. 1999;354:847–852
  12. Rodriguez WJ. Management strategies for respiratory syncytial virus infections in infants. J Pediatr. 1999;135(S):S45–S50
  13. The IMPACT-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531–537
  14. Simoes EAF, Groothuis JR. Respiratory syncytial virus prophylaxis. The story so far. Respir Med. 2002;96(Suppl B):S16–S25
  15. Khongphatthanayothin A, Wong PC, Samara Y, et al. Impact of respiratory syncytial virus infection on surgery for congenital heart disease: postoperative course and outcome. Crit Care Med. 1999;27:1974–1981
  16. Altman CA, Englund JA, Demmler G, et al. Respiratory syncytial virus in patients with congenital heart disease: a contemporary look at epidemiology and success of preoperative screening. Pediatr Cardiol. 2000;21:433–438
  17. Pohl C, Green M, Wald ER, et al. Respiratory syncytial virus infections in pediatric liver transplant recipients. J Infect Dis. 1992;165:166–169
  18. Palmer SM, Henshaw G, Howell DN, et al. Community respiratory viral infection in adult lung transplant recipients. Chest. 1998;113:944–950
  19. Committee on Infectious Diseases and Committee on Fetus and Newborn . Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112:1442–1452

PII: S0196-0709(05)00108-0

doi: 10.1016/j.amjoto.2005.05.012

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 27, Issue 1 , Pages 9-12 , January 2006

Article Tools